Transforming Cancer Care: Global Perspectives

This lecture delves into the integration of innovation within the European healthcare system, emphasizing the transformative initiatives and strategies aimed at combating cancer. Christine Chomienne, MD, PhD, provides insights drawn from her extensive experience and involvement in precision medicine training and cancer research.

Learning Objectives:

1. Gain insights into the evolution of precision medicine and its integration into the European healthcare system.

2. Understand the key initiatives and strategies launched to address cancer, including the BECA Committee and Europe's Beating Cancer Plan.

3. Explore the recommendations put forth by the Cancer Mission Board to transform cancer culture, communication, and capacity building across member states.

4. Appreciate the importance of cross-cutting actions and capacity building in reshaping cancer care and addressing societal challenges associated with the disease.

This document outlines key developments in the approach to scientific research, focusing on the mission-oriented approach to innovation and the Cancer Mission flagship initiatives within the European Union. It highlights initiatives such as Uncan.eu, the European Cancer Patient Digital Centre, and the Network of Comprehensive Cancer Infrastructures, aimed at enhancing understanding, prevention, diagnosis, treatment, and quality of life for cancer patients.

Learning Objectives:

1. Understand the concept of the mission-oriented approach to research and innovation, emphasizing its goal of addressing societal challenges and promoting equal access to innovation and research resources.

2. Explore flagship initiatives under the Cancer Mission, including Uncan.eu, the European Cancer Patient Digital Centre, and the Network of Comprehensive Cancer Infrastructures, and their objectives in improving cancer care.

3. Examine the actions outlined in the CANCER Mission implementation plan, such as competitive calls, portfolio approaches, workshops, and training sessions, aimed at fostering innovation and collaboration in cancer research and care.

4. Identify challenges in precision medicine (PM) training, including training diverse stakeholder communities and addressing literacy and motivation barriers in understanding complex and interdisciplinary scientific concepts.

This document emphasizes the critical role of policy makers in every stage of delivering precision medicine (PM) to citizens and patients. It highlights the importance of evidence-based decision-making, breakthroughs in prevention, diagnosis, treatment, and quality of life, as well as the need for increased knowledge, efficiency in care, economic return on investment (ROI), cultural transformation, capacity building, and coherence between Member States and institutions. Professor Mariana Mazzucato's insights underscore the significance of policy makers' involvement in shaping and implementing future European missions.

Learning Objectives:

1. Understand the multifaceted role of policy makers in advancing precision medicine, encompassing evidence provision, breakthrough delivery, and systemwide transformation.

2. Recognize the importance of policy makers' engagement in co-designing, co-creating, and co-implementing missions, fostering partnerships across sectors and actors.

3. Explore the methods and governance structures underlying mission-oriented research and innovation actions, emphasizing problem-focused approaches and systemwide transformation.

4. Reflect on the complexities of precision medicine, including economic considerations, and the imperative for policy makers to prioritize patient interests over commercial interests.

This section provides an overview of personalized medicine, exploring its definition and various flavors, including precision medicine, targeted therapy, and individualized medicine. It delves into the importance of personalized medicine in modern healthcare, highlighting its increasing prevalence in the market and its impact on FDA approvals.

Learning Objectives:

1. Understand the concept of personalized medicine and its different manifestations.

2. Recognize the significance of personalized medicine in healthcare, particularly its prominence in FDA approvals.

3. Explore the landscape of pharmacogenetics and its historical foundations, including ancient practices and modern advancements.

4. Gain insight into the difference between pharmacogenetics and pharmacogenomics, along with their applications in drug selection and dosing.

This segment delves into the historical roots of pharmacogenetics, tracing its origins from ancient practices to modern scientific discoveries. It explores pivotal moments in the field, such as Friedrich Vogel's coinage of the term "pharmacogenetics" and the identification of inherited determinants for drug effects. Additionally, it examines the role of technological advancements and the human genome project in accelerating pharmacogenetic research.

Learning Objectives:

1. Understand the historical foundations of pharmacogenetics, including ancient practices and early scientific observations.

2. Explore key milestones in the evolution of pharmacogenetics, from Friedrich Vogel's contributions to modern genomic studies.

3. Recognize the impact of technological advancements, such as the human genome project, on accelerating pharmacogenetic research.

4. Gain insight into the translation of pharmacogenetic discoveries into clinical implementation and point-of-care services.

This part focuses on the practical applications of pharmacogenetics in clinical settings, emphasizing the importance of continuous education for pharmacists and healthcare professionals. It explores resources and tools available for pharmacogenetic guidelines and discusses the significance of point-of-care DNA testing, using examples like the Spartan RX CYP2C19 System. The section concludes with insights into the global landscape of pharmacogenetic services, highlighting Egypt's contributions to point-of-care testing.

Learning Objectives:

1. Understand the importance of continuous education for pharmacists in implementing pharmacogenetic guidelines.

2. Explore available resources and tools for pharmacogenetic guidelines and clinical decision-making.

3. Recognize the significance of point-of-care DNA testing in personalized medicine, using the Spartan RX CYP2C19 System as a case study.

4. Gain insight into the global landscape of pharmacogenetic services, with a focus on Egypt's advancements in point-of-care testing.

This lecture delves into the high incidence and mortality rates of lung cancer in Croatia. It discusses the significance of lung cancer screening programs and the impact of initial stage diagnosis on survival rates. The speaker also highlights data from international trials like NLST and NELSON, emphasizing the importance of early detection and intervention.

Learning Objectives:

1. Understand the epidemiology of lung cancer in Croatia, including incidence, mortality rates, and survival trends.

2. Explore the role of lung cancer screening programs in improving early detection and reducing mortality rates.

3. Analyze the impact of initial stage diagnosis on the survival outcomes of lung cancer patients.

This lecture highlights Croatia's nationwide lung cancer screening program, launched on October 1st, 2020, under the leadership of academician Miroslav Samaržija. It discusses program eligibility, infrastructure, imaging protocols, multidisciplinary collaboration, AI integration, and continuous quality control. Moreover, it emphasizes the program's significance in improving early detection, reducing mortality, and providing comprehensive care.

Learning Objectives:

1. Understand the key components and objectives of Croatia's inaugural nationwide lung cancer screening program.

2. Explore the roles and responsibilities of various healthcare professionals, including GPs, radiologists, pulmonologists, and multidisciplinary teams, in the screening process.

3. Analyze the technical aspects of the screening program, including imaging protocols, AI integration, dose optimization, and quality control measures.

This lecture presents outcomes from Croatia's National Lung Cancer Screening Program spanning October 2020 to August 2023. It covers screening statistics, including scan results, findings, confirmed malignant cases, and radiation exposure. Surgical procedures and patient distribution across lung cancer stages are also discussed. Additionally, future initiatives, such as the Lung Nodule Clinic and expansion into other organ screenings, along with scientific projects, are outlined.

Learning Objectives:

1. Analyze the outcomes and findings of Croatia's National Lung Cancer Screening Program from 2020 to 2023.

2. Evaluate the distribution of scan results, confirmed malignant cases, and radiation exposure within the screening program.

3. Understand the future initiatives and scientific projects aimed at enhancing the effectiveness and scope of the lung cancer screening program in Croatia.

An overview of cancer prevalence, economic burden, prevalent cancers, and the journey towards universal health care in the Philippines.

Learning Objectives:

1. Understand the epidemiology and economic impact of cancer in the Philippines.

2. Identify prevalent cancers and associated risk factors.

3. Gain insights into the country's efforts towards universal health care and cancer control.

Exploration of the challenges and opportunities in implementing molecular diagnostics, including access issues, awareness, and infrastructure gaps, alongside potential opportunities for improvement.

Learning Objectives:

1. Recognize the barriers hindering the widespread adoption of molecular diagnostics in the Philippines.

2. Identify potential solutions and opportunities for enhancing molecular diagnostics infrastructure.

3. Understand the importance of stakeholder collaboration and advocacy in addressing these challenges.

Discussion on the path forward, emphasizing collaboration, regional initiatives, and strategies for advancing molecular diagnostics to improve cancer care and management in the Philippines.

Learning Objectives:

1. Explore strategies for enhancing collaboration among stakeholders in cancer care.

2. Understand the significance of regional collaboration and its impact on advancing cancer diagnostics.

3. Identify key steps and initiatives needed to accelerate the adoption of molecular diagnostics in the country.

An overview of key cancer risk factors, prevalent cancers, challenges in early detection, and access to cancer care in South Africa.

Learning Objectives:

1. Identify the leading cancers and risk factors prevalent in South Africa.

2. Understand the challenges faced in cancer care, including access issues and disparities.

3. Gain insights into the specificities of cancer epidemiology in South Africa and its impact on healthcare delivery.

Exploration of the role of next-generation sequencing (NGS) and molecular diagnostics in cancer care in South Africa, including its applications, benefits, and challenges.

Learning Objectives:

1. Understand the significance of NGS in cancer management, including its role in personalized medicine and targeted therapy.

2. Explore the implementation of molecular diagnostics in both public and private healthcare sectors.

3. Identify challenges and opportunities in integrating molecular diagnostics into cancer care pathways.

Discussion on the challenges faced in implementing molecular diagnostics, collaborative initiatives, and strategies for enhancing cancer care in South Africa.

Learning Objectives:

1. Identify key challenges in cancer care delivery and molecular diagnostics implementation.

2. Explore collaborative approaches and innovative solutions to address these challenges.

3. Understand the importance of value-based care and equitable access in cancer management.